Waverton Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$54.3M |
| 2 |
Microsoft
MSFT
|
+$32.1M |
| 3 |
Visa
V
|
+$29M |
| 4 |
US Bancorp
USB
|
+$17.4M |
| 5 |
MRSH
Marsh
MRSH
|
+$9.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$71.1M |
| 2 |
Mastercard
MA
|
+$21.9M |
| 3 |
Church & Dwight Co
CHD
|
+$12.6M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$11.6M |
| 5 |
Omnicom Group
OMC
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.28% |
| 2 | Communication Services | 18.88% |
| 3 | Technology | 17.76% |
| 4 | Industrials | 12.8% |
| 5 | Consumer Discretionary | 6.13% |
Similar funds
Waverton Investment Management's Q1 2017 Portfolio in Review
As of Q1 2017, Waverton Investment Management held 113 positions worth $1.58B, up 3.8% from $1.53B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Waverton Investment Management withdrew a net $61M in Q1 2017, closing 15 positions and reducing 51 holdings. Its most notable exit was Aon, an estimated $8.35M position sold in full.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Waverton Investment Management opened a new position in Biogen worth $52.5M.
- Waverton Investment Management's largest Q1 2017 buy was Biogen: 192,135 shares worth $52.5M.
- Waverton Investment Management added most to Microsoft in Q1 2017, an estimated $32.1M increase.
- Waverton Investment Management's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $71.1M.
- Waverton Investment Management fully exited Aon in Q1 2017, selling an estimated $8.35M.
- Waverton Investment Management's ten largest holdings make up 52% of its $1.58B portfolio in Q1 2017.
- Waverton Investment Management opened 3 new positions and closed 15 in Q1 2017.
- Waverton Investment Management's portfolio value rose 3.8% quarter-over-quarter to $1.58B.
Based on Waverton Investment Management's 13F filing for Q1 2017, filed 7 Apr 2017.